Macrophage Activation Syndrome in Children: Diagnosis and Management

被引:9
作者
Bagri, Narendra Kumar [1 ]
Gupta, Latika [2 ]
Sen, Ethan S.
Ramanan, A. V.
机构
[1] AIIMS, Dept Pediat, Div Pediat Rheumatol, New Delhi, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India
关键词
Hyper-inflammation; Secondary hemophagocytic lymphohistiocytosis; Juvenile idiopathic arthritis; JUVENILE IDIOPATHIC ARTHRITIS; FERRITIN; THERAPY; EMAPALUMAB; FEATURES; DISEASE;
D O I
10.1007/s13312-021-2399-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Macrophage activation syndrome is a severe yet under-recognized complication encountered in pediatric rheumatology. It manifests as secondary hemophagocytic lymphohistiocytosis leading to a hyper-inflammatory state resulting from an underlying cytokine storm. If unchecked, it may lead to multiorgan failure and mortality. Early diagnosis and timely initiation of specific therapy is pivotal for a successful outcome. This review outlines the key clinical and laboratory features and management of macrophage activation syndrome.
引用
收藏
页码:1155 / 1161
页数:7
相关论文
共 46 条
[1]   Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis [J].
Allen, Carl E. ;
Yu, Xiaoying ;
Kozinetz, Claudia A. ;
McClain, Kenneth L. .
PEDIATRIC BLOOD & CANCER, 2008, 50 (06) :1227-1235
[2]  
Bagri NK, 2020, PRINCIPLES PEDIAT NE, V4th, P538
[3]   Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis [J].
Balamuth, Naomi J. ;
Nichols, Kim E. ;
Paessler, Michele ;
Teachey, David T. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (08) :569-573
[4]  
Behrens EM, 2007, J RHEUMATOL, V34, P1133
[5]   Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis [J].
Boom, V. ;
Anton, J. ;
Lahdenne, P. ;
Quartier, P. ;
Ravelli, A. ;
Wulffraat, N. M. ;
Vastert, S. J. .
PEDIATRIC RHEUMATOLOGY, 2015, 13
[6]   Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus [J].
Borgia, R. Ezequiel ;
Gerstein, Maya ;
Levy, Deborah M. ;
Silverman, Earl D. ;
Hiraki, Linda T. .
ARTHRITIS & RHEUMATOLOGY, 2018, 70 (04) :616-624
[7]   Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome [J].
Bracaglia, Claudia ;
Prencipe, Giusi ;
De Benedetti, Fabrizio .
PEDIATRIC RHEUMATOLOGY, 2017, 15
[8]   Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment [J].
Carter, Stuart J. ;
Tattersall, Rachel S. ;
Ramanan, Athimalaipet V. .
RHEUMATOLOGY, 2019, 58 (01) :5-17
[9]   Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry [J].
Cetica, Valentina ;
Sieni, Elena ;
Pende, Daniela ;
Danesino, Cesare ;
De Fusco, Carmen ;
Locatelli, Franco ;
Micalizzi, Concetta ;
Putti, Maria Caterina ;
Biondi, Andrea ;
Fagioli, Franca ;
Moretta, Lorenzo ;
Griffiths, Gillian M. ;
Luzzatto, Lucio ;
Arico, Maurizio .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (01) :188-+
[10]   Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg [J].
Crayne, Courtney ;
Cron, Randy Q. .
EUROPEAN JOURNAL OF RHEUMATOLOGY, 2020, 7 :S13-S20